T3 hyperthyroidism with metastatic follicular thyroid carcinoma under substitution therapy;T3-Hyperthyreose bei metastasierendem follikularen Schilddrusenkarzinom unter Substitutionstherapie

NuklearMedizin

Volumn 35, Issue 5, 1996, Pages 186-189

  Lang, M ^a   Flesch, M ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

5' deiodination; follicular thyroidglandular Ca; T3 hyperthyroidism

Indexed keywords

IODINE 131; LEVOTHYROXINE; LIOTHYRONINE; DIAGNOSTIC AGENT; RADIOACTIVE IODINE; THYROGLOBULIN; THYROTROPIN; THYROXINE;

ADULT; ARTICLE; CASE REPORT; FEMALE; HUMAN; HYPERTHYROIDISM; METASTASIS; THYROID FOLLICULAR CARCINOMA; ADENOCARCINOMA; BLOOD; CANCER STAGING; LYMPH NODE METASTASIS; PATHOLOGY; RADIOGRAPHY; SCINTISCANNING; THYROID TUMOR;

ADENOCARCINOMA, FOLLICULAR; ADULT; FEMALE; HUMANS; HYPERTHYROIDISM; IODINE RADIOISOTOPES; LYMPHATIC METASTASIS; NEOPLASM METASTASIS; NEOPLASM STAGING; THYROGLOBULIN; THYROID NEOPLASMS; THYROTROPIN; THYROXINE; TRIIODOTHYRONINE;

EID: 0030255107     PISSN: 00295566     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0038-1629806     Document Type: Article

References (13)

1. 131Jod-speichernde pulmonale Metastasen differenzierter Schilddrüsenkarzinome bei niedrigem Thyreoglobulinspiegel - Ausnahme in der Tumornachsorge? J Nucl Med 1987; 26: 139-42.
2. Bauer W, Reiners Ch. In: Schilddrüsenmalignome. Diagnostik, Therapie und Nachsorge. Stuttgart - New York: Schattauer Verlag 1987.
3. Becker HD, Heinze HG. In: Maligne Schilddrüsentumore. Berlin - Heidelberg - New York: Springer Verlag 1984; S. 88-99.
4. Chapman CN, Sziklas JJ, Spencer RP, Bower BF, Rosenberg RJ. Hyperthyroidism with metastatic follicular thyroid carcinoma. J Nucl Med 1984; 25 (4): 466-8.
5. Georgi P, Emrich D, Heidenreich P et al. Radiojodtherapie des differenzierten Schilddrüsenkarzinoms. Nuklearmedizin 1992; 31: 151-3.
6. Köhrle J, Hesch R, Leonard J. Intracellular pathways of iodothyronine metabolism. In: Werner and Ingbar: The thyroid - a fundamental and clinical text. Braverman LE, Utiger RD, eds. Philadelphia: Lippincott 1991; 144-89.
7. Köhrle J, Oertel M, Hoang-Vu C, Schnieders F, Brabant G. Type I 5′-Deiodinase - a marker for differentiated thyroid carcinoma. Exp Clin Endocrinol 1993; 101: 60-72.
8. Müller OA, Leisner B, Löhrs U, Pichard CR. Hyperthyreose mit Struma maligna. Verb Dtsch Inn Med 1987; 54: 590-3.
9. Murakami T, Noguchi S, Murakami N, Tajiri J, Ohta Y. Destructive thyrotoxicosis in a patient with anaplastic thyroid cancer. Endocrinol Jpn 1989; 36: 905-7.
10. Pfannenstiel P, Saller B. Schilddrüsenkrankheiten: Diagnose und Therapie. 2. Auflage 1991. Berliner Medizinische Verlagsanstalt GmbH.
11. Schober O, Saur HB, Scink J, Ahrens S. Radioiodine therapy of malignant thyroid diseases. Exp Clin Endocrinol 1994; 102: 55-66.
12. Schreck R, Schnieders F, Schmutzler C, Köhrle J. Retinoids stimulate type I iodothyronine 5′-deiodinase activity in human follicular thyroid carcinoma cell lines. J Clin Endocrinol Metab 1994; 79: 791-8.
13. Staffurth JS, Holl-Allen RT. Follicular carcinoma of the thyroid following radioactive iodine treatment for Graves disease. Postgrad Med J 1988; 64: 878-80.